Archive: 16/11/2016

AHA: Evolocumab can help substantially reduce LDL

(HealthDay)—Combining statins with the PCSK9 inhibitor evolocumab can help reduce low-density lipoprotein (LDL) cholesterol to previously unseen levels, according to a study published online Nov. 15 in the Journal of the ...

Nov 16, 2016
popularity1 comments 0

GI adverse events up with GLP-1 receptor agonists

(HealthDay)—Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events (AEs), with risk varying based on dose, background medications, and type of GLP-1 ...

Nov 16, 2016
popularity0 comments 0